Menu
| Therapeutic Products | |||||
|---|---|---|---|---|---|
| Sr. No. | Product Name | Composition | Major Indications | Administration | Presentation |
| Antibiotics | |||||
| 1 | Biotrim | Biotrim Injection (IM) Each ml contains : Sulphadiazine IP : 400 mg Trimethoprim IP : 80 mg Biotrim Injection (IV) Each ml contains : Sulphadiazine IP : 200 mg Trimethoprim IP : 40 mg Chlorocresol IP : 0.1%w/v Biotrim DS Bolus - Each uncoated Bolus contains : Sulphadiazine IP : 2000mg Trimethoprim IP : 400 mg Excipients : q.s. | Calf Scour, Colisepticemia, enteritis & other bacterial infections | IV : 1 ml /20 kg b.w once daily for 3-5 days IM : 1 ml/30 kg b.w once daily for 3-5 days DS bolus : 1 bolus/100 kg b.w | 30 ml vial Blister of 4's |
| 2 | Cefstan | Each Vial contains Ceftriaxone sodium IP eq. to anhydrous ceftriaxone 3gm | Mastitis, Bronchitis, Pneumonia, Gastroenteritis, Peritonitis | Large animals: 10mg / kg b.w by IM/IV or SC route | 3 g vial with WFI |
| 3 | Dicrysticin-S LD Injection | Each Vial contains : Streptomycin Sulphate I.P. Equivalent to Streptomycin base 2.5gm Procaine Penicillin G I.P. 15,00000 units Penicillin G Sodium I.P 500,000 units | Mixed bacterial infections caused by penicillin and streptomycin sensitive organisms | Add 7.5 ml of sterile distilled water to make 10 ml suspension. To be administered by IM route. Large animals: 2 ml/ 50 kg b.w Small animals: 1 ml/ 50 kg b.w | 2.5 g vial |
| 4 | Dicrysticin-DS Injection | Each Vial contains Streptomycin Sulphate I.P Equivalent to Streptomycin base 5 gm Procaine Penicillin G I.P 3,000,000 units Penicillin G Sodium I.P 1,000,000 units | Mixed bacterial infections caused by penicillin and streptomycin sensitive organisms | Add 15 ml of sterile distilled water to make 20 ml suspension. To be administered by IM route. Large animals: 2 ml/ 50 kg b.w Small animals: 1 ml/ 50 kg b.w | 5 g vial |
| 5 | Enrodac-10 Injection | Each ml contains: Enrofloxacin IP 100 mg Benzyl Alcohol IP 1.5 % v/v (as preservative) Water for Injection IP q.s. | Mycoplasmosis, RTI, UTI, acute & chronic masititis, calf scour, salmonellosis | IM or slow IV injection. 1ml / 20kg b.wt. For 3-5 days in all animals | 100 ml vial |
| 6 | FPP-20 Injection | Each vial contains – Procaine Penicillin G IP : 15,00,000 units Penicillin G Sodium IP : 5,00,000 units | Diseases caused by penicillin sensitive organisms like anthrax, abscesses, mastitis, UTI, wounds, calf diphtheria, post-castration infections | Add 5 ml of distilled water to the vial. To be administered by IM route at 24 hour intervals. Large & medium sized animals: 4000 units/ kg b.w Small animals: 2,00,000 - 4,00,000 units | Vial |
| 7 | FPP-40 Injection | Each vial contains – Procaine Penicillin G IP : 30,00,000 units Penicillin G Sodium IP : 10,00,000 units | Diseases caused by penicillin sensitive organisms like anthrax, abscesses, mastitis, UTI, wounds, calf diphtheria, post-castration infections | Add 10 ml of distilled water to the vial. To be administered by IM route at 24 hour intervals. Large & medium sized animals: 4000 units/ kg b.w Small animals: 2,00,000 - 4,00,000 units | Vial |
| 8 | Marbodac Injection | Each ml contains Marbofloxacin IP 100mg M-cresol IP 2mg (as preservative) Water for injection IP qs | Mastitis caused by E.coli, Staphylococcus spp. & Streptococcus spp. Respiratory tract infections caused by Pasteurella multocida,Mannheimia haemolytica,Histophilus somni & Mycoplasma bovis | Cattle & Buffalo: 8 mg/kg b.w ie; 4 ml/50 kg b.w administered as single dose deep IM injection.If total dose is more than 20 ml, it should be divided & administered at two separate sites. | 30 ml vial |
| 9 | Marbodac-16 Injection | Each ml contains Marbofloxacin IP 160mg Benzyl alcohol IP 1.5%w/v (as preservative) Water for injection IP qs | Mastitis caused by E.coli, Staphylococcus spp. & Streptococcus spp. Respiratory tract infections caused by Pasteurella multocida,Mannheimia haemolytica,Histophilus somni & Mycoplasma bovis | Cattle & Buffalo: 8 mg/kg b.w ie; 4 ml/50 kg b.w administered as single dose deep IM injection.If total dose is more than 20 ml, it should be divided & administered at two separate sites. | 30 ml vial |
| 10 | Oriprim Bolus | Each uncoated bolus contains: Trimethoprim IP…………… 0.4 gm Sulphamethoxazole IP……….2.0 g Excipients ……………………q.s. | Actinobacillosis, actinomycosis, colibacillosis, mastitis, salmonellosis, urogenital infections | Large animals 4 boluses daily; small animals ½ to 1 bolus daily | Blister of 4's |
| 11 | Oriprim Injection | Each 5 ml contains : Trimethoprim IP : 80 mg Sulphamethoxazole IP : 400 mg Water for injection IP : qs | Actinobacillosis, actinomycosis, colibacillosis, mastitis, salmonellosis, urogenital infections | IV injection. Large animals 15 -30 ml; Small animals 2-5 ml daily | 30 ml vial |
| 12 | Oriprim U Bolus | Each film coated bolus contains : Trimethoprim I.P. 0.1 g Sulphamethoxazole I.P. 0.5 g Urea I.P. 6 g Excipients q.s. | Post-partum diseases like retained Placenta,metritis, pyometra, cervicitis & vaginitis | Intra-uterine 2-4 boluses | Blister of 4's |
| 13 | Oxynex | Each ml contains: Oxytetracycline Hydrochloride IP 50mg Propylene glycol IP q.s. | HS, Anthrax, BQ, Actinobacillosis, actinomycosis, colibacillosis, mastitis, salmonellosis, urogenital infections, Theileriosis, secondary bacterial complications of viral diseases | IV, IM, SC injection. 1 ml / 10 kg b.w | 100 ml vial |
| 14 | PAM Injection | Each ml contains : Penicillin G Procaine IP : 3,00,000 units Aluminum monostearate USP 2% Oily base qs | Mastitis, metritis, abscesses, anthrax, BQ, wounds, navel ill, docking | IM injection deeper into the muscles. Large animals 8000 IU/ kg b.w | 10 ml vial |
| 15 | Pathocef | Each Vial contains Sterile sulbactum Sodium USP equivalent to sulbactum…………..1.5gm Sterile cefoperazone sodium IP equivalent to cefoperazone…….3.0gm | Bovine Mastitis, Metritis & Soft Tissue infections | Cattle & Buffaloes : 10 mg/kg b.w by IM or IV route for 3-5 days at 24 hrs interval | 4.5 g vial with water for injection |
| 16 | R C Forte D | Each vial contains Sterile Ampicillin Sodium IP eq. to Ampicillin …2gm Sterile Dicloxacilin Sodium IP eq. to Dicloxacilin…..2gm | Mastitis, Septicaemia, chronic wounds & post surgical therapy | Cattle & Buffaloes : 6-10mg/kg b.w by I/M, IV route for 3-5 days | 4 g vial with WFI |
| 17 | Steclin Injection | Each ml contains: Oxytetracycline Hydrochloride IP eq. to anhydrous Oxytetracycline 50 mg Propylene Glycol IP q.s. | HS, Anthrax, BQ, Actinobacillosis, actinomycosis, colibacillosis, mastitis, salmonellosis, urogenital infections, Theileriosis, secondary bacterial complications of viral diseases | IV, IM, SC injection. 1 ml / 10 kg b.wt. | 30 ml, 50 ml & 100 ml vial |
| 18 | Steclin-LA Injection | Each ml contains: Oxytetracycline Dihydrate IP equivalent to anhydrous oxytetracycline 200 mg in 2 - pyrrolidone vehicle system Water for Injection IP …. qs | Pasteurellosis, Mastitis, Metritis, Pneumonia, Foot rot, Anaplasmosis, Theileriosis, secondary bacterial complications of viral diseases | IM injection deeper into the muscles 1 ml / 10 kg b.w | 30 ml & 100 ml Vial |
| 19 | Steclin Bolus | Each uncoated Bolus contains: Tetracycline Hydrochloride IP 500 mg Exciplents q.s. Colour: Tartrazine Yellow Supra | Calf scours, bacterial enteritis, navel ill, foot-rot, pyometra,metritis | Oral: 2-4 bolus. Intra-uterine 1-2 bolus | Strip of 4's |
| 20 | Sulpha Bolus | Each uncoated tablet contains: Sulphadimidine IP…………… 5.0 gm Excipients ……………………q.s. | Calf scours, bacterial enteritis, acute bacterial infections | 1-2 bolus per 50 kg b.wt. followed by half the dose daily for 3-5 days. | Blister of 4's |
| 21 | Vetclox Forte Injection | Each vial contains Ampicillin Sodium IP equivalent to anhydrous Ampicillin : 1 gm Cloxacillin Sodium IP equivalent to anhydrous Cloxacillin : 1 gm | Pneumonia, septicemia, enteritis, colitis, urogenital infections, infectious dermatitis | Add 10ml of sterile distilled water to make the solution administer IM or slow IV @ 5-10 mg kg b.wt. Repeat every 24 hours for 3-5 days. | 2 g vial |
| Anti-histaminic | |||||
| 1 | Cadistin Injection | Each ml contains - Chlorpheniramine maleate IP : 10 mg Phenylmercuric nitrate IP : 0.002% w/v (as preservative) Water for Injection IP q.s. | Allergic reactions with acute respiratory signs, rhinitis,eczema,insect bite & asthama | IM injection Large animals 3-5 ml, Small animals 0.5-1 ml | 30 ml & 100 ml vial |
| Anti-parasitic | |||||
| 1 | Duromect Injection | Each ml contains Doramectin 10 mg Benzyl alcohol IP 9 mg (as preservative) Oily base qs | Cattle, Sheep & Goat: Treatment and control of gastrointestinal roundworms, parafilaria, eye worm, lung worm, screw worm, sucking lice, mange mites & single host ticks Swine: Controls roundworms & lung worm. Also kills sarcoptic mange mites & lice | Cattle, Sheep & Goat: 200 µg/ kg b.w by IM or SC route Swine: 300 µg/ kg b.w by IM route | 10 ml & 50 ml vial |
| Anti-protozoal | |||||
| 1 | Babimido Injection | Each ml contains Imidocarb dipropionate 120 mg Aqueous base qs | Treatment & Control of Babesiosis & Anaplasmosis | Cattle, Sheep & Goat Babesiosis: Treatment: 1 ml/ 100 kg b.w by IM/ SC route Prevention: 2.5 ml/ 100 kg b.w by IM/SC route (1 to 2 month effect) Anaplasmosis: 2.5 ml/ 100 kg b.w by IM/SC route Horse: 2 ml/ 100 kg b.w by IM route (may be repeated after 24 hrs in acute cases of equine babesiosis) Dog: 0.5 ml/ 10 kg b.w by SC route (two doses two weeks apart in canine babesiosis/ehrlichiosis) | 10 ml vial |
| 2 | Butazyd Injection | Each ml contains Buparvaquone IP 50 mg Sorbitan mono oleate IP 100mg (as preservative) Oily base qs | Specific treatment for Theileriosis | IM injection 1 ml per 20 kg b.w. | 20 ml vial |
| Corticosteroids | |||||
| 1 | Dexona Injection | Each ml contains : Dexamethasone sodium phosphate IP 4.4 mg equivalent to Dexamethasone 3.344 mg Methyl paraben IP : 0.15% w/v Propyl paraben IP : 0.02% w/v (as preservatives) Water for injection IP : qs | Ketosis, inflammation of respiratory tract or urogenital tract, anaphylactic shocks, surgical shocks, acute mastitis | IM or slow IV injection. Cattle, buffalo & horse 4 -20 mg daily; calves, pig, sheep & goat 2-4 mg daily; dog & cat 0.5 -2 mg daily. | 5 ml vial |
| 2 | Isoflud Injection | Each ml contains : Isoflupredone acetate IP : 2 mg Benzyl alcohol IP : 9 mg (as preservative) Water for injection IP qs | Bovine Ketosis, inflammatory conditions such as laminitis, traumatic arthritis, osteoarthritis, myositis, mastitis, metritis, pneumonia etc. | Deep IM injection. Cattle & Buffaloes 5-10 ml, horses 2.5 – 10 ml, small animals 1 ml per 10 kg. For local effect directly into joint cavity. | 5 ml, 10 ml & 30 ml vial |
| 3 | Vetalog Injection | Each ml contains : Triamcinolone acetonide IP : 6 mg Benzyl alcohol IP : 0.9% v/v (as preservative) Water for injection IP : QS | Bovine ketosis, arthrits, tenosynovitis, allergy, pruritus, haematoma, inflammatory conditions. | Bovine Ketosis 2-5 mg to 10 mg IM; Arthritis, Tenosynovitis 6-18 mg intra-articular. Other conditions – Large animals 12 -20 mg IM or SC, Small animals 0.1 – 0.2 mg/kg IM or SC injection. | 5 ml vial |
| Hormones | |||||
| 1 | Clostenol Injection | Each ml contains : Cloprostenol sodium IP : 263 mcg equivalent to 250 mcg of Cloprostenol Water for Injection IP : qs | Induction and synchronization of heat, Persistent Corpus Luteum, termination of pathological pregnancy, pyometra, mummified foetus, induction of parturition | IM injection. Cattle & buffaloes 2 ml. Mares 0.5 – 2 ml; sheep, goat & pig 0.5 – 1ml. In bitch to terminate mismatching pregnancy 1 mcg/ kg b.wt and To treat metritis & Pyometra 1 mcg/ kg b.wt. | 2 ml vial |
| 2 | P-Depot Injection | Each ml contains : Hydroxyprogesterone caproate : 250 mg Oily base qs | Threatened & habitual abortion, repeat breeding, prolapse of uterus | IM injection deeper into the muscles 1 ml – 2ml. | 2 ml, 3 ml ampoule |
| 3 | Zydarelin | Each ml contains Buserelin acetate 4.2mcg eq to Buserelin IP 4mcg Benzyl alcohol IP 1 %w/v water for injection IP qs | Cattle & Buffalo : Infertility of Ovarian Origin & improvement of Conception rate, Early induction of oestrous cycle after calving, follicular cysts, improvement of conception rate in artificial imsemnation procedures, synchronisation of oestrous with PGF2 alpha analogue | Cattle : 10 to 20 mcg Mare : 20 to 40 mcg Fertility disorders of Ovarian Origin Cattle & Buffalo: True Anoestrus 5 ml Synchronisation of Oestrous 2.5 ml Follicular Cyst 5 ml Delayed ovulation 2.5 ml Improvement of conception in A.I 2.5 ml | 2.5 ml, 5ml & 10 ml vial |
| Infusions | |||||
| 1 | Bovilyte | Each 100 ml contains Dextrose (anhydrous)-20 gm Sodium chloride IP -0.600 gm Potassium chloride IP-0.600 gm Potassium chloride IP-0.040 gm Calcium chloride dehydrate IP-0.040 gm Sodium lactate: 0.312 gm | Calf Scour, diarrhea,debility, dehydration | Slow IV infusion | 500 ml |
| 2 | Milk Fever Formula | Each 450 ml provides Calcium 8.37 g, magnesium 2.09 g, phosphorous 5.32 g Dextrose anhydrous 90 g, proportion of Boric acid to Calcium in the injection is 2.26 to 1 | Milk Fever, Hypocalcemia, Hypomagnesia, Hypophosphataemia | Slow IV infusion | 450 ml |
| 3 | VetPlasma | Each 100 ml contains Hydroxyethyl Starch : 6.0 gm (130/0.4) Sodium Chloride : 0.9 gm | Acute Hypovolemia, associated with Conditions like Haemoprotozoan diseases, Diarrhoea | Slow IV infusion | 500 ml,250 ml |
| Intramammary | |||||
| 1 | Pendistrin-SH | Single dose (6ml) contains Procaine Penicillin G IP : 1,00,000 units Streptomycin sulphate IP eq to 100 mg Streptomycin base Sulphamerazine BP. : 0.5gm Hydrocortisone acetate IP : 20 mg Sterile base q.s. | Acute or chronic mastitis | One tube after each milking in the affected quarter for 2-3 days | 6 ml tube |
| 2 | Pendizyd | Each syringe 6ml contains Procaine Penicillin G I.P 1,00,000 units Streptomycin Sulphate I.P eq. to Streptomycin base 100 mg Sulphadimidine IP 0.5 g Hydrocortisone Acetate I.P. 20 mg in sterile base | Treatment of acute & chronic mastitis in lactating cows & buffaloes Dry Cow Therapy | Utilize the antiseptic swab to clean and disinfect the affected teat of the animal. Instill the content of one pre-filled syringe of Pendizyd into each infected quarter till animal freshens. Mastitis: 1 syringe into each affected quarter of the udder after every milking for three consecutive milkings. The treatment can be extended in consultation with the veterinarian. Dry Cow Therapy: 1 syringe into each quarter of the udder at the time of drying-off | 6 ml pre filled syringe |
| 3 | Uddercef | Each prefilled syringe contains Cefuroxime sodium equivalent to Cefuroxime 250 Mg Liquid paraffin IP …QS | Acute or chronic mastitis | One tube after each milking for 3 consecutive milking | 3.5 g syringe |
| Mineral Injections | |||||
| 1 | Alphos-40 | Each ml contains: Sodium Acid Phosphate IP 400 mg (Equivalent to 79.4 mg of elemental Phosphorus) Methyl Paraben IP (as preservative) 0.1 %w/v Water for Injection IP qs | Post- parturient paresis,hypophosphatemia, tetany, paraplegia, delayed puberty,delayed oestrus, silent heat, repeat breeding | Acute cases: Large animals 5,10 or 25ml. Small animals 1 to 3 ml (Half the dose to be given IV, theother half SC or IM, divided over several sites. Injection should be repeated at frequent interval till improvement is visible. Chronic cases: 5-15 ml, small animals 1-2 ml | 30 ml vial |
| 2 | Injectiphos | Each ml contains: Butaphosphan 100 mg Cyanocobalamin IP (Vitamin B12) 0.05mg N-Butyl Alcohol (as preservative) 3%v/v Water for Injection IP q.s. | Low productivity, post-partum metabolic disorders like ketosis, infertility, stress conditions | SC/IM/IV injection. Large animals 10 – 25 ml, Sheep & Goat 2.5 – 8ml, Foal & Calf 5-12 ml. | 30 ml & 100 ml vial |
| 3 | Minjet Injection | Each ml contains: Zinc ( as Zinc EDTA) : 40mg Manganese (as Manganese EDTA) : 10mg Copper (as Copper EDTA) : 15mg Selenium : 5mg | For Growth, Fertility and Production. | Growth -1 ml per 50 kg body weight Fertility- 1 ml per 75 kg body weight in Heifers 1 ml per 100 kg body weight in Large Animals Production: 1 ml per 100 kg body weight | 10 ml and 30 ml Vial |
| Non-steroidal Anti-inflammatory Drugs | |||||
| 1 | Artizone -S | Each ml contains Phenyl Butazone IP 200mg SodiumSalicylate IP 20 mg | Inflamation of Joints, muscles, & Skeletal tissues, Pyrexia | 20-30 ml first two days followed by half of the dose on subsquent days by I/M route | 30 ml & 100 ml vial |
| 2 | Flunimeg Injection | Each ml contains Flunixin meglumine IP 83mg eq to Flunixin 50.0 mg Phenol IP 5.0mg (as preservative) Excipients qs | Colic, inflammation, pain & fever, arthritis, myositis, mastitis, pneumonia | IM or IV injection. Cattle, buffaloes, sheep & goat 1-2 ml/45 kg b.wt., Horse 1ml / 45 kg, pigs 2 ml/ 45 kg, dogs 0.5 – 1ml, | 10 ml, 30 ml vial |
| 3 | Karpofen Injection | Each ml contains Carpofen IP 50mg Benzyl alcohol IP 1.04%w/v (as preservative) Water for injection IP qs | Musculoskeletal disorders like arthritis, osteitis, tendonitis,myositis, Acute mastitis, Pneumonia, & Bronchitis, Post operative pain management | Cattle : 1.4 mg/kg (1 ml /35 kg b.w) by IM,IV or SC route as a single dose | 10 ml & 30 ml Vial |
| 4 | Neoprofen Injection | Each ml contains: Ketoprofen IP 100 mg Benzyl Alcohol IP 1%w/v Water for Injection IP q.s. | Acute and chronic inflammatory conditions like mastitis,arthritis, myositis,surgical pain & colic | Cattle & Buffalo : 3mg/kg b.w by IM,IV or SC route | 15 ml & 100 ml Vial |
| 5 | Oxalgin-NP Bolus | Each uncoated bolus contains: Nimesulide BP…………… 400 mg Paracetamol IP……………1500 mg Excipients ……………………q.s. | Osteoarthritis, myositis, bursitis, tenosynovitis, bursitis, pyrexia of unknown origin | Large animals: 1 -2 bolus Small animals: ½ to 1 bolus | Blister of 4 boluses |
| 6 | Oxal Forte Bolus | Each bolus contains Nimesulide BP 400 mg Paracetamol IP 1500 mg Serratiopeptidase IP 75 mg Excipients qs | Wounds, abcesses, injury, mastitis, metritis & post surgical therapy | Large Animals: 1-2 boli Small Animals: 1/2 - 1 bolus | Blister of 2's |
| 7 | Zobid-M Injection | Each ml contains - Meloxicam IP : 5 mg Benzyl alcohol IP : 2% v/v (as preservative) water for injection IP : qs | Osteoarthritis, myositis, bursitis, tenosynovitis, bursitis, pyrexia of unknown origin | Large animals 1ml / 10kg b.wt. Small animals 1ml / 10 kg. | 15 ml, 30 ml & 100 ml vial |
| 8 | Zobid Bolus | Each uncoated Bolus contains: Meloxicam IP…………… 100 mg Excipients ……………………q.s. | Arthritis, Synovitis, Myositis, Laminitis, bursitis, tendonitis, otitis, post-operative pain | Large animals 1 -2 bolus; small animals ½ to 1 bolus | Blister of 4 boluses |
| 9 | Zobid-MP Injection | Each ml contains - Meloxicam IP - 5 mg Paracetamol IP 150 mg Lignocaine HCl IP 1% w/v Water for injection IP qs | Osteoarthritis, myositis, bursitis, tenosynovitis, bursitis, pyrexia of unknown origin | IM injection. Large animals 15 -20 ml; small animals 0.5 – 1 ml/ 10 kg b.wt. | 30 ml, 100 ml vial |
| 10 | Meloximol Injection | Meloxicam BP 20 mg + Ethanol BP 150 mg | Injection | 50 ml, 100 ml | |
| Ruminotoric Bolus | |||||
| 1 | Bovirum Bolus | Each uncoated Bolus contains: Antimony Potassium Tartrate USP 2.0 gm Dried Ferrous Sulphate IP 2.0 gm Copper Sulphate Anhydrous BP 50 mg Cobalt Chloride 100 mg Excipients q.s. | Indigestion, Anorexia | 3 to 4 boluses per day. Provide plenty of drinking water to the treated animal | Blister of 4's |
| Tranquilizers & Sedatives | |||||
| 1 | Siquil Injection | Each ml contains : Triflupromazine hydrochloride : 20 mg Benzyl alcohol IP : 1.5% (as preservative) Sodium chloride IP : 0.2% in Water for injection IP | Failure to let-down of milk, prolapse of uterus and vagina, as a pre-anesthetic agent in surgeries, restraint of excited animals, nausea & vomiting | IM or IV injection. 10-20 mg / 100 kg b.wt. Dogs 1 – 4 mg / kg b.wt. | 5 ml vial |
| Thymomimetic | |||||
| 1 | Lemasol Injection | Each ml contains: Levamisole HCI IP 75 Mg Benzyl Alcohol IP (as preservative) 1.5%w/v Water for Injection IP qs | Reduce severity, duration & frequency of infections, reduces chances of relapse of mastitis & helps to control FMD outbreaks | 1 ml/ 30 kg b.w by SC route only | 30 ml vial |
| Vitamin injections | |||||
| 1 | Belamyl Injection | Each ml contains : Thiamine hydrochloride IP : 10 mg Riboflavin IP : 3 mg Niacinamide IP : 100 mg Vitamin B12 IP : 10 mcg Liver Injection Crude (having Vit. B12 activity equivalent to 2mcg of cyanocobalamin per ml) Phenol IP : 0.5% Water for injection IP : QS | Non-specific anorexia, during convalescence, liver disorders, debility and general weakness | IM injection. Large animals 5-10 ml on alternate days. Small animals 0.25– 0.5 ml twice weekly. | 10 ml, 30 ml, 50 ml & 100 ml vial |
| 2 | Hivit Plus | Each ml contains Vitamin A IP 1000IU Vitamin D3 IP 500IU Niacinamide IP 10mg Thaimine HCL IP 10mg Pyridoxine HCL IP 5 mg Riboflavine Sodium Phosphate IP 5mg Cyanocobalamine IP 10mcg D-Biotin BP 10mcg D-Penthenol IP 1mg Choline Chloride 5mg Alpha Tocopheryl acetate IP 5mg Sodium acid phosphate IP 10mg Water for Injection IP q.s. | Non-specific anorexia, during convalescence, debility and general weakness | 1 ml / 30kg b.w I/M on alternate days for 3-5 days | 30 ml & 100 ml vial |
| 3 | Neuroxin-M Injection | Each ml contains : Methylcobalamin IP 500mcg Pyridoxine HCl IP 50 mg Nicotinamide IP 50 mg Benzyl alcohol IP 2% v/v Water for injection IP qs | Neurological disorders, anorexia, fatty liver degeneration, anemia, post-parturient paresis, as a supportive therapy with antibiotics | IM or IV injection. Large animals 5-10 ml for 3-5 days. Dogs 2-3 ml daily for 3-5 days | 10 ml, 30 ml & 100 ml vial |
| 4 | Vetade Injection | Each ml contains: Vit A (as palmitate) IP 250000 IU Vit D3 IP 25000 IU Vit E (as di-alpha Tocopheryl acetate) IP 100 IU Benzyl alcohol IP 2%w/v as preservative Sesame oil USP qs | Prevention & treatment of vitamin A, D3 & E deficiencies, repeat breeding, muscle dystrophy, poor conception or lowered fertility rate | Deep IM injection. For prophylaxis: Cattle & Buffaloes 4-6 ml, horses 2 ml, small animals 1- 2 ml. For treatment: Cattle & Buffaloes 6-10 ml, horses 4 ml, small animals 2 ml. | 10 ml vial |
| 5 | Neuroxin-MS 2500 | Each ml contains: Methylcobalamin IP 2500mcg Benzyl Alcohol IP 2% v/v (As Preservative) | In the treatment of: Neuronal Disorders like lameness, improper gait, lack of body coordination, Ataxia Anaemia, General debility, Downer cow syndrome In the Support of: During last trimester of pregnancy, weekly injection for foetal development Weekly injections in growing calves and heifers | Cow, Buffalo, Horse: 5-10ml/day Calves, Sheep, Goat: 2-3ml/day Dogs: 1 ml/20Kg BW (Duration of treatment can be increased as per the severity of deficiency or as recommended by Veterinarian) | 10 ml and 30 ml vial |
| Feed Supplement | |||||
| 1 | TissuAid | Each Tablet contains: Blend of Proteolytic Enzymes,derived from Plant, Fungal and Bacterial Sources (Proteolytic activity not less than 25000 IU) | Benefits: Helps to improve healing of udder tissues Helps to accelerate wound healing in conditions like Open wound / Post-operative / Deep seated wound Helps to reduce swelling in Oedematous & other Inflammatory conditions | Suggestive Usage: Large Animals: 3 tablets twice a day for 3 to 5 days Small Animals: 1 tablet twice a day for 3 to 5 days | TissuAid tablets are available in 5 Strips X 6 Tablets |
An inveterate traveler, a great number cruncher and a man who know show to back the right start-up, Chairman Sushil Mehta has donned many hats. With a post graduate degree in Microbiology, he has rich work experience with companies like Glaxo Labs, Ranbaxy and Becton Dickinson on the business side. He led the Management Buy Out(MBO) of the allied business of Ranbaxy by ICICI Venture capital fund in 2005.
As CEO of the newly formed enterprise RFCL Ltd he divested the businesses by 2011, thus creating handsome returns for the stakeholders. In 2011, after being acquired by Avant or Performance Materials through New Mountain Capital (a New York-based PE fund)he was part of the Global Leadership team as EVP – Lab & Diagnostics and India Region. In 2015, with thirty-five years of experience in the Life Sciences Industry he turned Angel Investor with an aim to associate with start-ups and help them build teams and achieve operational excellence.
Andrew Yee joined IFC’s Asset Management Company in 2014 as Co- head of the Emerging Asia Fund, overseeing investments across a diverse range of industries in India, Sri Lanka, Bangladesh, the Philippines, Vietnam, China and Myanmar. With over two decades of experience in private equity, industry and banking, Andrew has made a significant impact in his previous roles. Prior to his tenure at IFC, he held key positions at Standard Chartered Bank Private Equity and Inter Gen Asia. His expertise in infrastructure investments and his strategic contributions to the industry have been widely acknowledged. Andrew holds a Bachelor of Commerce degree (majoring in Accounting) and a Bachelor of Laws degree from the University of New South Wales in Sydney, Australia.
Mr. Utpal Sheth brings a wealth of expertise to the board, with a distinguished career spanning over 30 years in
the Indian capital markets. He serves as the CEO and Senior Partner at RARE Enterprises, a multi-billion-dollar
proprietary asset management firm. In this role, Mr. Sheth directs his extensive experience towards long-term
investments in both the public markets and private equity. His adept portfolio construction and risk management
skills contribute to the firm’s success. As an advocate for sustainable value creation, Mr. Sheth actively
engages with investee companies, fostering an environment that enhances shareholder value. His strategic
insights and keen understanding of market dynamics drive growth and innovation.
Furthermore, Mr. Sheth is the Founder and Mentor of TRUST Group, a prominent player in the fixed income space
that has evolved into a n extensive financial institution. His leadership within TRUST Group is characterised by
a focus on strategic direction, institutionalisation and effective team building. Mr. Utpal Sheth’s extensive
experience, strategic vision and commitment to excellence make him an invaluable asset to the board.
Dr. Arun Atrey serves as the Managing Director and CEO of Zenex Animal Health India Private Limited. With an impressive 38 years of experience, including 36 years of dedicated service to the Zydus Cadila Group (Now Zydus Lifesciences), Dr. Atrey brings a wealth of expertise to his role. With a degree in Veterinary Science and a post graduate degree in business management (University Topper & Gold Medallist), his remarkable journey began in 1985 when he joined Cadila Veterinary as a Product Executive after a short stint in the FMCG industry. He was given the complete responsibility of building the animal health business of Cadila in1986 as its Business Head. He played a pivotal role in the joint venture between Zydus Cadila and Ambalal Sarabhai Enterprises Ltd. in 2000 and continued to lead the new JV as its COO and Whole -time Director.
Under Dr. Atrey’s leadership, Zydus Cadila achieved significant milestones – introducing numerous ground breaking veterinary products to the Indian market. These achievements led to Zydus Animal Health being recognised as the best Animal Health Company in India, the Middle East and Africa by Animal Pharm, UK in 2015, 2017 and 2018. In addition, the Company received prestigious awards such as ‘The Best Poultry Company Award’ in 2010 (IPJA) and 2014 (Poultry Fortune) , among others.
Dr. Arun Atrey actively engages in the Animal Health industry. He is a Founder Director and a Past President (2015-2017) of INFAH (Indian Federation of Animal Health Companies). He is also the Chairman of the ‘Therapeutic & Disinfectant Subcommittee’ of INFAH. His contributions to the industry have been recognised through honours and awards, including the ‘Best CEO in the Poultry Industry 2018 Award’ instituted by the Poultry Fortune Group. Dr. Atrey’s insights and expertise make him a sought-after speaker at industry forums, management and veterinary institutes. He is also a member of expert committee of IPC veterinary group.
Manish Gaur is an investment professional with nearly 20 years of experience, serving as a Nominee Director for
Zenex. He joined Multiples in 2019 after spending over 14 years with The Carlyle Group, where he focused on
investments in pharmaceuticals, technology, business services, consumer goods and industrial sectors. With a
background in equity research at prominent firms like Credit Suisse and Deutsche Bank, Manish brings a wealth of
knowledge to his role. At Multiples, he leads investments across pharmaceutical, healthcare, enterprise tech,
industrial and logistics sectors.
Manish holds a post graduate diploma in management from the Indian Institute of Management (IIM), Ahmedabad and
a Bachelor of Technology degree from the Indian Institute of Technology (IIT), Bombay. He is also a CFA charter
holder.
Ms. Renuka Ramnath is the Founder, Managing Director and CEO of Multiples Alternate Asset Management, a private
equity manager and advisor to funds of ~ USD 3bn in AUM. Renuka Ramnath is one of the most experienced private
equity fund managers in India, with a career of over 35 years in financial services.
Ms. Ramnath started her career with the ICICI group which culminated in becoming the MD & CEO of ICICI
Venture. She was instrumental in building it into one of the largest private equity funds in the country. In
2009,she established Multiples, an India-focused private equity platform, driven by her passion for supporting
entrepreneurs and fostering sustainable businesses. Ms.Ramnath’s exceptional leadership and contributions have
earned her recognition as one of the most powerful women in business and she has been honoured with prestigious
awards and accolades. She holds a Bachelor of Engineering degree from VJTI and an MBA from the University of
Mumbai. Additionally, she has completed the Advanced Management Program at Harvard Business School.